Genprex Inc

Genprex Inc is an American clinical-stage gene therapy company focused on developing innovative treatments for diabetes and cancer. Its primary aim is to create potentially life-saving medicines using its unique, proprietary gene delivery platform. Operating within the healthcare sector, Genprex Inc specialises in its gene delivery systems. This approach seeks to enhance the effectiveness of gene therapies, potentially improving outcomes for patients with challenging cancers, while helping institutions find new routes towards healthcare solutions. Keep up to date on the latest share price changes by adding GNPX stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.